Feb 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bayer, RWE and GSK, on Wednesday.
HIGHLIGHTS
* Euro Pharma: Berenberg ups GlaxoSmithkline to buy, cuts Bayer to hold
* Statoil : HSBC cuts to neutral from overweight
* Nokia : UBS adds to its most preferred list
* RWE : Barclays raises to equal weight from underweight
Following is a summary of research actions on European ...
Sign in to access
this Article
"EUROPE RESEARCH ROUND-UP: Statoil, GSK, Nokia" is part of the paid WardsAuto Premium content. You must log in with Premium credentials in order to access this article. To obtain Premium status, please contact us.
Why Become a Premium Subscriber?
WardsAuto.com Premium subscribers have access to the full breadth of Ward’s articles, news, analysis and features as well as all the Ward’s data and statistics as soon as they are available in Excel spreadsheet format. Learn more about the benefits of Premium access here.
